BioLife Solutions, Inc. (BLFS) — Financial statements
Income statement, balance sheet, and cash flow for BioLife Solutions, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 96↑17.0% | 82↑8.4% | 76↓0.5% | 76↓36.0% | 119 | |
| Cost of Revenue | 34↑19.3% | 29↓70.4% | 97↑229.1% | 29↓67.5% | 90 | |
| Gross Profit | 62↑15.7% | 54↑14.8% | 47↓0.3% | 47↑62.6% | 29 | |
| Operating Expenses | ||||||
| R&D Expenses | 8↓4.4% | 8↓57.9% | 19↑27.0% | 15↑25.2% | 12 | |
| General & Administrative Expenses | 46↑12.3% | 41↓6.3% | 43↑30.1% | 33↓2.5% | 34 | |
| Selling & Marketing Expenses | 10↑2.5% | 10↓24.4% | 13↑8.9% | 12↓16.6% | 14 | |
| SG&A Expenses | 55↑10.4% | 50↓10.4% | 56↑24.6% | 45↓6.6% | 48 | |
| Other Expenses | 11↑313.3% | 3↓93.6% | 43↑721.2% | -7↓151.3% | 13 | |
| Operating Expenses | 74↑22.1% | 61↓48.3% | 118↑122.5% | 53↓28.0% | 73 | |
| Total Costs & Expenses | 108↑21.2% | 89↓10.0% | 99↑20.9% | 82↓46.8% | 154 | |
| Operating Results | ||||||
| Operating Income | -12↓70.2% | -7↑69.6% | -23↓295.7% | -6↑83.2% | -35 | |
| Depreciation & Amortization | 0.00↓100.0% | 9↓29.6% | 12↓38.4% | 20↑55.1% | 13 | |
| EBITDA | -9↓711.9% | 2↑103.4% | -45↑63.6% | -124↓645.7% | -17 | |
| EBIT | -9↓31.5% | -7↑72.2% | -26↓140.1% | -11↑65.2% | -31 | |
| Interest & Other Income | ||||||
| Net Interest Income | -3↓276.4% | -0.72↑60.3% | -2↓163.8% | -0.69↓41.6% | -0.49 | |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Expense | 3↑276.4% | 0.72↓60.3% | 2↑163.8% | 0.69↑41.6% | 0.49 | |
| Non-Operating Income | -3 | 0.00↓100.0% | 2↓53.9% | 5↑205.4% | -5 | |
| Other Income / Expenses | 0.05↑101.1% | -4↓186.5% | 5↑362.2% | 1↓82.5% | 6 | |
| Income Before Tax | -12↓5.7% | -11↑38.1% | -18↓281.0% | -5↑83.3% | -29 | |
| Income Tax Expense | 0.05↑228.9% | -0.04↓258.3% | 0.02↑100.5% | -5↑74.0% | -20 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -12↓6.5% | -11↑38.3% | -18↓4854.4% | 0.39↑104.4% | -9 | |
| Net Income from Discontinued Operations | 0.00↑100.0% | -9 | 0.00↑100.0% | -140 | 0.00 | |
| Net Income | -12↑39.9% | -20↑69.6% | -66↑52.5% | -140↓1469.4% | -9 | |
| Bottom-Line Net Income | -12↑39.9% | -20↑69.6% | -66↑52.5% | -140↓1469.4% | -9 | |
| EPS (Basic) | -0.25↑43.2% | -0.44↑71.1% | -1.52↑53.8% | -3.29↓1330.4% | -0.23 | |
| EPS (Diluted) | -0.25↑43.2% | -0.44↑71.1% | -1.52↑53.8% | -3.29↓1330.4% | -0.23 | |
| Weighted Average Shares | 48↑3.7% | 46↑5.4% | 44↑2.9% | 42↑10.3% | 39 | |
| Weighted Average Diluted Shares | 49↑5.6% | 46↑5.4% | 44↑2.9% | 42↑10.3% | 39 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.